FDA cGMP Requirements for PET Drugs

被引：0

作者：

Norenberg, Jeffrey P.

Schwarz, Sally

VanBrocklin, Henry

机构：

来源：

JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

收藏

页码：16N / 16N

页数：1

相关论文

共 50 条

[41] FDA approves landmark drugs
不详
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 177 - 177
[42] FDA warns on imported drugs
不详
CHEMICAL & ENGINEERING NEWS, 2002, 80 (50) : 27 - 27
[43] FDA and Fluoroquinolone Antibacterial Drugs
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (10) : 1188 - 1189
[44] FDA weighs in on nitrosamines in drugs
Erickson, Britt
CHEMICAL & ENGINEERING NEWS, 2020, 98 (34) : 15 - 15
[45] Meeting FDA process validation requirements
SIMS Deltec, St. Paul, United States
Medical Device and Diagnostic Industry, 1996, 18 (07):
[46] CURRENT STATUS OF FDA TOXICITY REQUIREMENTS
FANCHER, OE
CALANDRA, JC
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 153 (A1) : 258 - &
[47] DRUGS + FDA - REVIEW PROCEDURES
RAVDIN, IS
SCIENCE, 1964, 146 (364) : 12 - &
[48] FDA: "No" to antiviral drugs in poultry
不详
VETERINARY ECONOMICS, 2006, 47 (05): : 30 - 30
[49] Immunosuppression, Generic Drugs and the FDA
Trofe-Clark, J.
Gabardi, S.
McDevitt-Potter, L.
Alloway, R. R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 792 - 793
[50] GMP/FDA requirements to aseptic production
Langer, U
Mangel, A
PHARMAZEUTISCHE INDUSTRIE, 2002, 64 (04): : 375 - 383

← 1 2 3 4 5 →